StockNews.com Begins Coverage on Actinium Pharmaceuticals (NYSE:ATNM)

Published on 22 May 2023 on ETF DAILY NEWS

StockNews.com initiated coverage on shares of Actinium Pharmaceuticals (NYSE:ATNM – Get Rating) in a...

Read the rest of the article

Start tracking your investments with Statfolio

StockNews.com initiated coverage on shares of Actinium Pharmaceuticals (NYSE:ATNM – Get Rating) i...

ETF DAILY NEWS 22 May 2023

In response to the market action, I'm managing positions tightly, holding high levels of cash and...

TheStreet.com 18 Jan 2023

Investors are up against overbought technical conditions and some frothy sentiment as we head int...

TheStreet.com 2 Jan 2023

We have some random, but positive action as investors position in front of important economic new...

TheStreet.com 11 Dec 2022

Finch Therapeutics Group, Inc. (FNCH) came out with a quarterly loss of $0.45 per share versus th...

Zacks via Yahoo Finance 15 Nov 2022

HAMILTON, ON and BOSTON, Nov. 7, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN),...

WIBW Topeka 7 Nov 2022

The Dow Jones Industrial Average finished with its best October performance ever on Monday, despi...

MarketWatch 31 Oct 2022

Shares of Actinium Pharmaceuticals Inc. were up 22.8% in trading on Monday after the company met ...

MarketWatch 31 Oct 2022

Actinium Pharmaceuticals Inc (NASDAQ: ATNM) announced positive topline results from the pivotal P...

Benzinga via Yahoo Finance 31 Oct 2022

Actinium Pharmaceuticals (ATNM) shares rallied 8.6% in the last trading session to close at $7.92...

Zacks via Yahoo Finance 26 Oct 2022